|
LAPTM4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.553300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.942200E-03 |
| Normal-vs-Stage2 |
6.212300E-02 |
| Normal-vs-Stage3 |
1.833220E-01 |
| Normal-vs-Stage4 |
7.106800E-01 |
| Stage1-vs-Stage2 |
7.037800E-01 |
| Stage1-vs-Stage3 |
7.262000E-01 |
| Stage1-vs-Stage4 |
4.014400E-01 |
| Stage2-vs-Stage3 |
5.490200E-01 |
| Stage2-vs-Stage4 |
2.811800E-01 |
| Stage3-vs-Stage4 |
5.484600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.022790E-03 |
| Normal-vs-AfricanAmerican |
2.132000E-02 |
| Normal-vs-Asian |
5.559400E-01 |
| Caucasian-vs-AfricanAmerican |
5.885400E-01 |
| Caucasian-vs-Asian |
8.028600E-01 |
| AfricanAmerican-vs-Asian |
9.162600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.901300E-03 |
| Normal-vs-Female |
3.281200E-03 |
| Male-vs-Female |
2.637800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.415000E-01 |
| Normal-vs-Extreme_Weight |
3.383600E-02 |
| Normal-vs-Obese |
1.523610E-03 |
| Normal-vs-Extreme_Obese |
8.319600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.272800E-01 |
| Normal_Weight-vs-Obese |
1.068550E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.705000E-01 |
| Extreme_Weight-vs-Obese |
1.834230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.653200E-01 |
| Obese-vs-Extreme_Obese |
1.913390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.563500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.235700E-04 |
| Normal-vs-Age(61-80Yrs) |
3.622300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.068970E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.253600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.191200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.366400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.903900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.449200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.134200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.15310000003976E-06 |
| Normal-VS-Type2 PRCC |
8.799200E-01 |
| Normal-VS-KIRP CIMP |
2.960100E-02 |
| Normal-VS-Unclassified PRCC |
3.026100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.5008000000003E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.014200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.963400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.021380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.805730E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.828400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.415400E-01 |
| Normal-vs-N1 |
1.866830E-01 |
| Normal-vs-N2 |
3.077400E-01 |
| N0-vs-N1 |
5.555200E-01 |
| N0-vs-N2 |
7.717600E-01 |
| N1-vs-N2 |
9.996000E-01 |
|
|
